Clinical Trial Update: Alpha Lipoic Acid in Pediatrics on Hemodialysis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating alpha-lipoic acid in pediatric patients on hemodialysis; currently enrolling by invitation. Sponsor: Ain Shams University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease Pediatric
• Chronic Kidney Disease
• End-stage Renal Disease Pediatric

Drugs mentioned

• Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: Ain Shams University | Conditions: Hemodialysis Complication, Pediatric Kidney Disease | Phase 3 | Status: ENROLLING_BY_INVITATION